NME21 Program

NME21 is a global event including keynotes, parallel sessions about academic research in Nanomedicine (ENM), translation towards the clinic & trends in disruptive medical technologies (ETPN). Social events will also  give you lots of opportunities for networking.

program

Day 1 –  Sept, 7

}

11:00am – 12:30pm

ETPN Association, General Assembly (part 1)

By the ETPN Bureau & Secretariat

FOR ETPN MEMBERS ONLY.

FOR ETPN MEMBERS ONLY.

}

12:30pm – 01:30pm

Lunch Break and networking

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

01:30pm – 02:30pm

ETPN Working Groups meetings

By the ETPN WG chairpeople

FOR ETPN MEMBERS ONLY.

FOR ETPN MEMBERS ONLY.

}

02:30PM – 03:00PM

Official welcome by Mayor Pappa from St.Gallen

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

03:00PM – 03:15PM

virtual Lab tour Dept. “Materials meet Life”

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

03:15PM – 04:00PM

Keynote Andre Nel, UCLA

Multi-functional Nanocarrier Platforms for Anti-cancer Immunity in Heterogeneous Tumor Microenvironments through Immunogenic Cell Death

 

 

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.

Day 2 – September, 8

}

11:00am - 11:45am

NME21 official opening ceremony

B. Damann, Councilor Kanton St.Gallen

G.-L. Bona, Director Empa

Dr. Germann, Director Kantonsspital St.Gallen

Prof. Ehrenzeller, Rector University St.Gallen

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

11:45am - 12:30pm

KEYNOTE: Andreas Kuhn, BioNTech

 

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

12:30PM – 01:45PM

Lunch break, Postersession

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.

ETPN event

ENM scientific conferences

}

01:45pm - 02:45pm

Olma Messen

Pitch me Up! session*

SUBMIT YOUR ABSTRACT

FOR ETPN MEMBERS ONLY.

Nucleic Acid Nanomedicines*

Chairs: Gerrit Borchard (University of Genova) & Ruth Schmid (ETPN / SINTEF)

CLICK FOR INFO & SPEAKERS

Nucleic acid based vaccines have certainly made a strong entrance to fend off the current pandemic. This will pave the way for future applications of nucleic acids in both, preventive and therapeutic medical products for a number of indications such as immuno-oncology and rare diseases. With some of these future products already in company pipelines, we would like to shed light and invite for abstracts on the fundamental and conceptual research ongoing in this area of future medicines along the whole value chain from formulation and characterization to design for specific disease and tissue targeting.

Invited Speakers

  • Prof. Olivia Merkel – LMU Munich
  • Prof. Dan Peer – Tel Aviv University
  • Selected speakers (submit your abstract!)
}

02:45PM – 03:00PM

short break

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

03:00Pm - 4:00pm

Nanomedicine in Horizon Europe*

Moderator: Alexandre Ceccaldi (ETPN)

DETAILS COMING SOON

Biomedical Imaging Technologies*

Chairs: Alex Dommann (Empa) & Alessia Pica (Paul Scherrer Institute)

CLICK FOR INFO & SPEAKERS

Biomedical imaging has become an indispensable technology of everyday clinical practice. Imaging offers a new route to enhanced analyses of tissue architecture, which may give access to novel information of prognostic and predictive value and is therefore used not only for diagnostics but also for post-treatment monitoring. Imaging technologies offer a continuous better resolution, 3D rendering provides a holistic view of the area of interest or can be integrated as an online tool known as advanced reality to support complex interventions even better. The large size of the feature-rich datasets requires a multi-level data integration framework based on modern data science methods. This session will shed light on the newest development in imaging technologies, tissue analysis workflow using multi-level data integration and how imaging can contribute to new insights at the nanoscale.

Invited Speakers

  • Prof Dr Raphael Sznitmann (ARTORG Bern)
  • Enrico Capobianco – University of Miami
  • Selected speakers (submit your abstract!)

Day 3 – September, 9

ETPN event

ENM scientific conferences

}

11:00am-12:00am

Health technologies for Disruptive medicine

Chair: Furio Grammatica (Fondazione Don Gnocchi) & Bernd Wollscheid (ETH)

DETAILS COMING SOON

Clinical Translation of Nanomedicine*

Chairs: Scott McNeil (University of Basel) & Maria Kavallaris (UNSW Sydney)

CLICK FOR INFO & SPEAKERS

The past several decades of nanomedicine research have generated a plethora of particle types, which can accommodate a variety of drug chemistries.  The subsequent translation of these formulations into clinical trials requires the investigator to also evaluate the drug’s pharmacokinetic (PK) and toxic liabilities, as part of the overall ADME/Tox profile.  This session will offer some insights and lessons learned in these important topics, such as avoiding undesired side effects.

Invited Speakers

  • Maria Kavallaris (UNSW Sydney)
  • Vicky Stone (Heriot-Watt University)
  • Selected speakers (submit your abstract!)
}

12:00am - 01:00pm

Brokerage event

DETAILS COMING SOON

FOR ETPN MEMBERS ONLY.

Nanomedicine today & tomorrow*

Chairs: Beatrice Schirmer-Beck (University of Zürich) & Miodrag Filipovic (Kantonsspital St.Gallen)

CLICK FOR INFO & SPEAKERS

Nanomedicine is a very active research field and many novel concepts are in development beyond the well-established lipid technologies and passive targeting. In this session, innovative strategies will be discussed. Some examples are: The use of the outstanding properties of nanoscaled materials for unmeet clinical needs, or the impact of treatments by programmed nanoparticles that have an autonomous capacity to synthesize diagnostic and therapeutic compounds.

Invited Speakers

  • Prof. IK Herrmann (Empa/ETHZ)
  • Avi Schröder  (Technion – Israel Institute of Technology)
  • More to be announced
  • Selected speakers (submit your abstract!)
}

1:00Pm – 2:00pm

Lunch break, Postersession

 

}

02:00Pm - 03:00pm

European projects in Nanomedicine

Moderator: Alexandre Ceccaldi (ETPN)

DETAILS COMING SOON

Digital Therapeutics and Nanomedicines *

Chairs: Alexander Geissler (HSG – University of St. Gallen) & Tobias Kowatsch (ETH Zürich)

CLICK FOR INFO & SPEAKERS

Digital therapeutics are used for the prevention, treatment and management of diseases with a strong focus on digital biomarkers (“sensing”) and behavioral medicine (“support”). By contrast, nanomedicine uses nanotechnology for diagnosis, delivery, sensing or actuation in living organisms. The combination of both digital therapeutics and nanomedicine has the potential to push forward the boundaries of just-in-time adaptive interventions, triggered at opportune moments in advance of critical health conditions or adverse health behaviors. This session will shed light on different developments and discuss further the interconnectedness and applications in diagnostics, therapeutics and prevention for various diseases.

Invited Speakers

  • Therese Triemer (Novartis Oncology)
  • Others invited speakers to be announced soon.
  • Selected speakers (submit your abstract!)
}

03:00PM - 03:45PM

KEYNOTE: Christine Allen, University of Toronto

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.
}

03:45PM – 04:00PM

Poster prize & NME21 closing ceremony

Mauris id finibus tortor. Sed urna velit, sagittis ut tristique a, finibus id mauris. Morbi euismod purus eget orci lobortis, consequat tempus nisi iaculis. Sed porta odio vitae nunc molestie euismod. Ut dui erat, faucibus non ipsum quis, aliquet odio.

Register Now!

Don’t wait to register online for NME21! Would you be a young scientist, a project manager in Nanomedicine, an entrepreneur, a clinician, working in Pharma or MedTech industry, NME21 is a unique opportunity to meet new collaborators and share your success story!

Contact Us